# Pneumococcal Conjugate Vaccine in Aging Renal Transplant

> **NCT03802994** · EARLY_PHASE1 · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 57 (actual)

## Conditions studied

- Renal Transplantation
- Aging

## Interventions

- **DRUG:** 23 valent pneumococcal polysaccharide vaccine
- **BIOLOGICAL:** 13 valent conjugated pneumococcal vaccine
- **OTHER:** Peripheral blood sample

## Key facts

- **NCT ID:** NCT03802994
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-01
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-02-28
- **Target enrollment:** 57 (ACTUAL)
- **Why stopped:** Due to COVID pandemic further recruitment of subjects was unethical.
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03802994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03802994, "Pneumococcal Conjugate Vaccine in Aging Renal Transplant". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03802994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*